Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transdermal lisuride for restless legs syndrome
2004-001589-42Phase 3Active
- Sponsor
- NeuroBiotec
- Start
- Nov 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of lisuride in restless legs syndrome (RLS) (4 arms), sponsored by NeuroBiotec. Primary endpoint: Primary: Change in IRLS total score from baseline to Week 12 (Visit 6 / Day 85). Started Nov 2004; status: active.
02
Drugs
lisuride
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on 2004-001589-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001589-42.